Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.Translational Oncology.  12:84-95. 2019
2018 Systemic Thrombolysis of an Occlusive Aortic Thrombus in a Neonate on Extracorporeal Membrane Oxygenation.American Surgeon.  84:e372-e374. 2018
2018 Systemic Thrombolysis of an Occlusive Aortic Thrombus in a Neonate on Extracorporeal Membrane Oxygenation.American Surgeon.  84:e372-e374. 2018
2018 A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.Journal of Surgical Research.  228:54-62. 2018
2018 Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.Oncotarget.  9:22665-22679. 2018
2017 Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.Human Gene Therapy Clinical Development.  28:7-16. 2017
2017 Rationale and Design of a Phase I Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.Human Gene Therapy Clinical Development2017
2016 Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma.Translational Oncology.  9:419-430. 2016
2016 Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.Translational Oncology.  9:263-273. 2016
2016 Early Trauma-Induced Coagulopathy is Associated with Increased Ventilator-Associated Pneumonia in Spinal Cord Injury Patients.Shock.  45:502-505. 2016
2016 Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.Molecular Cancer Therapeutics.  15:911-921. 2016
2016 Oncolytic virotherapy for pediatric malignancies: future prospects.Oncolytic Virotherapy.  5:73-80. 2016
2015 Surgical management and morbidity of pediatric magnet ingestions.Journal of Surgical Research.  199:137-140. 2015
2015 Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.Molecular Cancer Therapeutics.  14:1559-1569. 2015
2015 Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.Journal of Surgical Research.  196:339-349. 2015
2015 Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Molecular Therapy - Oncolytics.  2. 2015
2015 Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.Molecular Therapy - Oncolytics.  2. 2015
2014 Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.PLoS ONE.  9:e86843. 2014
2014 The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.Current Medicinal Chemistry Anticancer Agents.  14:46-51. 2014
2013 Detection of Salmonella in Shellfish Using SYBR Green™ I-Based Real-Time Multiplexed PCR Assay Targeting invA and spvBFood Analytical Methods.  6:922-932. 2013
2013 Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.PLoS ONE.  8:e77753. 2013
2010 Safety and utility of scheduled nonnarcotic analgesic medications in children undergoing craniotomy for brain tumor.Neurosurgery.  67:353-355. 2010

Education And Training

  • Bachelor of Science or Mathematics in Biology / Biological Sciences, University of Alabama at Birmingham
  • Doctor of Medicine, University of Alabama at Birmingham
  • Full Name

  • Alicia Waters
  • Blazerid

  • alicia